PA
IDYA icon

Profund Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Profund Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Sell
32,938
-6,361
-16% -$195K 0.03% 303
2026
Q1 		$1.31M Sell
39,299
-7,816
-17% -$262K 0.05% 276
2025
Q4 		$1.63M Buy
47,115
+26,424
+128% +$842K 0.05% 257
2025
Q3 		$563K Sell
20,691
-2,684
-11% -$64.9K 0.02% 473
2025
Q2 		$491K Sell
23,375
-2,257
-9% -$43.3K 0.02% 469
2025
Q1 		$420K Buy
25,632
+2,031
+9% +$43.3K 0.02% 535
2024
Q4 		$607K Sell
23,601
-1,973
-8% -$55.9K 0.02% 420
2024
Q3 		$810K Buy
25,574
+2,751
+12% +$104K 0.03% 376
2024
Q2 		$801K Sell
22,823
-9,099
-29% -$360K 0.03% 361
2024
Q1 		$1.4M Sell
31,922
-54
-0.2% -$2.32K 0.05% 257
2023
Q4 		$1.14M Buy
31,976
+9,633
+43% +$288K 0.05% 303
2023
Q3 		$603K Sell
22,343
-929
-4% -$23.6K 0.03% 414
2023
Q2 		$547K Sell
23,272
-788
-3% -$16.2K 0.03% 485
2023
Q1 		$330K Buy
+24,060
New +$401K 0.02% 669

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Profund Advisors's IDYA Position: Q2 2026 in Review

Profund Advisors reduced its IDEAYA Biosciences (IDYA) stake by 16% in Q2 2026, selling an estimated $195K and leaving 32,938 shares worth $1.23M. The position accounts for 0.03% of the portfolio, ranked #303.

Profund Advisors first reported a position in IDYA in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.63M in Q4 2025. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Profund Advisors held 32,938 shares of IDEAYA Biosciences worth $1.23M as of Q2 2026.
  • Profund Advisors sold 6,361 IDEAYA Biosciences shares in Q2 2026, an estimated $195K.
  • IDEAYA Biosciences made up 0.03% of Profund Advisors's portfolio in Q2 2026, its #303 holding.
  • Profund Advisors first reported a position in IDEAYA Biosciences in Q1 2023 and has held it in 14 quarters since.
  • Profund Advisors's IDEAYA Biosciences position peaked at $1.63M in Q4 2025.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.